Article
Molecular basis of β thalassemia and potential therapeutic targets.
Blood cells, molecules & diseases - 1 May 2018
Thein Swee Lay
Abstract excerpt
The remarkable phenotypic diversity of β thalassemia that range from severe anemia and transfusion-dependency, to a clinically asymptomatic state exemplifies how a spectrum of disease severity can be generated in single gene disorders. While the genetic basis for β thalassemia, and how severity of the anemia could be modified at different levels of its pathophysiology have been well documented, therapy remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
